Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares
Public ClinicalTrials.gov record NCT00610363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study, Tolerability, and Efficacy of Rilonacept for the Prevention of Gout Flares During Initiation of Allopurinol Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a clinical research study to determine the safety and effectiveness of an experimental drug called rilonacept in participants with gout who were beginning another additional treatment. Participants participated in this study for approximately 24 weeks. Rilonacept was being studied for use in preventing gout attacks in participants who had gout.
Study identification
- NCT ID
- NCT00610363
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- May 2, 2017
2007 – 2008
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | San Diego | California | 92108 | — |
| Not listed | Santa Maria | California | 93454 | — |
| Not listed | Whittier | California | 90601 | — |
| Not listed | Colorado Srings | Colorado | 80910 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Orlando | Florida | 32804 | — |
| Not listed | St. Petersburg | Florida | 33710 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Dunwoody | Georgia | 30338 | — |
| Not listed | Honolulu | Hawaii | 96814 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Indianapolis | Indiana | 46268 | — |
| Not listed | South Bend | Indiana | 46601 | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Wheaton | Maryland | 20902 | — |
| Not listed | Billings | Montana | 59101 | — |
| Not listed | Omaha | Nebraska | 68114 | — |
| Not listed | Reno | Nevada | 89502 | — |
| Not listed | Albany | New York | 12206 | — |
| Not listed | Plainview | New York | 11803 | — |
| Not listed | Roslyn | New York | 11576 | — |
| Not listed | Monroe | North Carolina | 28112 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Mayfield Village | Ohio | 44143 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Duncansville | Pennsylvania | 16635 | — |
| Not listed | West Reading | Pennsylvania | 19611 | — |
| Not listed | Charleston | South Carolina | 29406 | — |
| Not listed | Grenville | South Carolina | 29601 | — |
| Not listed | Dallas | Texas | 75235 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00610363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00610363 live on ClinicalTrials.gov.